Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor

Mostrar otras versiones (1)

The COVID-19 pandemic spurred a broad interest in antiviral drug discovery. The SARS-CoV-2 main protease (M(pro)) and papain-like protease (PL(pro)) are attractive antiviral drug targets given their vital roles in viral replication and modulation of host immune response. Structurally disparate compo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Haozhou, Ma, Chunlong, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978949/
https://www.ncbi.nlm.nih.gov/pubmed/35378761
http://dx.doi.org/10.21203/rs.3.rs-1490282/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978949/
https://www.ncbi.nlm.nih.gov/pubmed/35378761
http://dx.doi.org/10.21203/rs.3.rs-1490282/v1

Ejemplares similares